ÂÜÀòÂÒÂ×

Debbie Martin is an experienced Regional Senior Clinical Research Associate with a robust background in overseeing and managing clinical trials, particularly in studies involving cystic fibrosis, pulmonary diseases, and COVID-19. Currently at ReCode Therapeutics since January 2024, Martin engages in a Phase 1/2 multicenter study on RCT2100. Previous roles include significant contributions at Armata Pharmaceuticals and Pulmocide, where duties included managing complex, multi-center trials with a focus on safety and efficacy evaluations. Martin's career spans a range of prestigious organizations, consistently demonstrating expertise in clinical research operations and regulatory compliance across various therapeutic areas. Holding a Bachelor of Science in Food Science and Technology from North Carolina State University, Martin combines scientific knowledge with exceptional clinical oversight.